Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Klass Russell Kevin. Director active across 1 company, notably Zomedica Corp.. In total, 4 reports have been published. Split: 4 buys · 0 sell. Total volume traded: €139k. Activity tracked since 10 June 2024. The latest transaction was filed on 17 March 2025 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.